Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
coronavirus
Pharma
Moderna's CEO takes slight pay cut during 'transition year'
As Moderna transitions away from COVID-19, the company's CEO, Stéphane Bancel, saw his total compensation drop roughly 12% in 2023.
Fraiser Kansteiner
Mar 12, 2024 10:47am
After cuts, Novavax's Q4 performance startles investors
Feb 28, 2024 9:38am
Moderna's manufacturing operations reveal state of the company
Feb 22, 2024 10:15am
Novavax paying up to $400M to evade Gavi COVID shot arbitration
Feb 22, 2024 6:00am
Pfizer adds another country to its list of COVID shot lawsuits
Jan 19, 2024 9:22am
Millions of Paxlovid doses are headed for the bin in Europe
Jan 2, 2024 2:49pm
